Status:
COMPLETED
Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Myocardial Infarction
Eligibility:
All Genders
Brief Summary
To monitor the safety of Metalyse® in clinical practice in patients with acute myocardial infarction over a period of 6 years as required by Korean authorities, with the following observations: 1. Un...
Eligibility Criteria
Inclusion
- none
Exclusion
- none
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
987 Patients enrolled
Trial Details
Trial ID
NCT02206646
Start Date
February 1 2003
Last Update
August 1 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.